Rising Pharmaceuticals to enter deferred prosecution agreement over generic drug price-fixing
MLex Summary: Rising Pharmaceuticals will enter a deferred prosecution agreement with the US Department of Justice over charges that it fixed prices on generic Benazepril HCTZ, a medicine used to treat...To view the full article, register now.
Already a subscriber? Click here to view full article